These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22546780)

  • 21. The potential utility of HPV genotyping in screening and clinical management.
    Castle PE
    J Natl Compr Canc Netw; 2008 Jan; 6(1):83-95. PubMed ID: 18267061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening based on papillomavirus detection: too many false alarms.
    Prescrire Int; 2010 Aug; 19(108):178-9. PubMed ID: 20939456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV testing in cervical screening.
    Cuzick J
    Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
    [No Abstract]   [Full Text] [Related]  

  • 24. Human Papillomavirus in Kidney Transplant Recipients.
    Chin-Hong PV
    Semin Nephrol; 2016 Sep; 36(5):397-404. PubMed ID: 27772624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.
    Banović M; Mahovlić V; Salopek KM; Banović V; Babić I; Orešković S; Babić D
    Pathol Oncol Res; 2015 Jul; 21(3):613-7. PubMed ID: 25432549
    [No Abstract]   [Full Text] [Related]  

  • 30. The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.
    Stoler MH; Wright TC; Parvu V; Vaughan L; Yanson K; Eckert K; Karchmer T; Kodsi S; Cooper CK
    Gynecol Oncol; 2018 Jun; 149(3):498-505. PubMed ID: 29681462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
    Franco EL
    J Natl Cancer Inst; 2009 Dec; 101(23):1600-1. PubMed ID: 19903806
    [No Abstract]   [Full Text] [Related]  

  • 32. Cervical screening in adolescents--at least do no harm.
    Szarewski A; Sasieni P
    Lancet; 2004 Nov 6-12; 364(9446):1642-4. PubMed ID: 15530605
    [No Abstract]   [Full Text] [Related]  

  • 33. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
    Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
    Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?
    Cox JT
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s5-s13. PubMed ID: 16520683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal cytology in 2012: management of atypical squamous cells, low-grade intraepithelial neoplasia, and high-grade intraepithelial neoplasia.
    Garrett LA; McCann CK
    Clin Obstet Gynecol; 2013 Mar; 56(1):25-34. PubMed ID: 23337842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical Cancer Screening Guideline for Individuals at Average Risk.
    Chor J; Davis AM; Rusiecki JM
    JAMA; 2021 Dec; 326(21):2193-2194. PubMed ID: 34766970
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening adolescents and young women.
    Boardman LA; Robison K
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):257-68. PubMed ID: 23732030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.